Market Size (2017)
2017
$4.80B
Healthcare
Acne Treatment Market
By Segment, By Region, And Segment Forecasts, 2017 – 2027
Vertical: HealthcareBase Year: 201913 Sections
Executive Summary
Acne Treatment Market — Snapshot
Projected (2027)
2027
$7.43B
CAGR (2017–2027)
4.5%
4.5%Key Players
108+
Acne treatment involves administration of several forms of medications and ointments to lighten the tone of affected areas. A balanced diet is also considered as a key factor for acne treatment, and this factor has played a major role in the growth of the global acne treatment market. Moreover, the rising need for improved medications for acne treatment has brought in voluminous investments in the global acne treatment market.
Factors such as the increasing prevalence of acne vulgaris condition in teenager and adults, rising sedentary lifestyle and unhealthy food habits and growing demand for minimally invasive cosmetic treatment procedures have boosted the demand and propelled the market growth. However, safety issues regarding the products being applied for acne treatment are the posing hurdles to the market growth on the country level.
Key Insight
The Acne Treatment Market market is projected to grow at a CAGR of 4.5% from 2017 to 2027.
Market Performance Trend
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Scope & Coverage
What this report covers
- Geographic Coverage: This analysis covers 4 regions: Europe, Asia Pacific, Middle East and Africa, Americas.
- Market Segmentation: The market is analyzed across 3 segments: Moderate Acne, Mild Acne, Moderate to Severe Acne. Forecasts are provided for each segment from 2017 to 2027.
- Competitive Landscape: 108 leading companies are profiled, covering market positioning, strategies, and recent developments.
Market Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Overview
Acne Treatment Market — Growth Trajectory
The scope of the global acne treatment market study includes the market size analysis and a detailed analysis of the different products/software and strategies. The market has been segmented based on acne type, treatment type, drug type, route of administration (ROA), end user, and region.
Acne Treatment Market — Growth Trajectory
Moderate Acne
Mild Acne
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size Trend (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Dimensions
How this market is segmented
- Acne Treatment_Type Acne Treatment_Type is broken down into: Moderate Acne, Mild Acne, Moderate to Severe Acne.
- Treatment Treatment is broken down into: Medication, Therapeutic Devices.
- Drug Type Drug Type is broken down into: OTC, Prescription.
- Route of Administration Route of Administration is broken down into: Topical, Oral, Injectable.
- End User End User is broken down into: Hospitals and Clinics, Specialty Centers, Others.
Geographic Analysis
Regional market breakdown
- Europe Europe market size reached $2.83B in 2017 and is projected to reach $4.40B by 2027, growing at a CAGR of 4.5%.
- Asia Pacific Asia Pacific market size reached $548.54M in 2017 and is projected to reach $905.56M by 2027, growing at a CAGR of 5.1%.
- Middle East and Africa Middle East and Africa market size reached $162.04M in 2017 and is projected to reach $223.15M by 2027, growing at a CAGR of 3.3%.
- Americas Americas market size reached $1.26B in 2017 and is projected to reach $1.91B by 2027, growing at a CAGR of 4.2%.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Methodology
Acne Treatment Market — How We Researched This Market
This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2019
Historical Period
2017 – 2019
Forecast Period
2019 – 2027
Primary Interviews
150+
Research Process
Historical data (2017–2019) and forecast period (2019–2027)
1
Problem Definition
- Market scoping
- Objective setting
- Framework design
2
Secondary Research
- Literature review
- Data mining
- Trend analysis
3
Primary Research
- Expert interviews
- Field visits
- Surveys
4
Data Analysis
- Quantitative modeling
- Statistical testing
- Validation
5
Insights & Reporting
- Synthesis
- Recommendations
- Visualization
Research Depth
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Historical vs. Forecast Data
Historical (observed)
Forecast (modelled)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCompetitive Landscape & Porter's Five Forces
Acne Treatment Market — Competitive Analysis
Bargaining Power of Suppliers
There are numerous raw material suppliers in the market, indicating that the manufacturers have the liberty to shift between suppliers. Moreover, the suppliers are not concentrated in any one region but have a global presence, which minimizes the switching costs for manufacturers. Therefore, the bargaining power of suppliers in the global acne treatment market is high.
Bargaining Power of Buyers
The presence of several players in the global acne treatment market has attracted a wide consumer base. Owing to a large number of existing manufacturers in the market, the switching costs for consumers is high. Moreover, the consumers are well-informed about the various products available in the market, and their brand loyalty is high. However, the product portfolios offered by the key players are extensive, which creates the possibility of a brand switch. Additionally, consumers are price-sensitive, which is a significant factor in their bargaining power.
Thus, the bargaining power of buyers is moderate in the global acne treatment market.
Threat of New Entrants
The acne treatment product manufacturers have to emphasize on product development and launch products with extra features. The new players need moderate capital investments to set up their businesses and position their brands in a manner that attracts consumer attention. However, advertising and other promotional campaigns require a significant level of investment. Consumers in the market possess a high level of brand loyalty, and new players require time to create a positive brand image. On the other hand, if a player is providing a product at a competitive price, the threat of the new entrant will be high. Thus, the threat of new entrants in the market is high.
Threat of Substitutes
In the acne treatment market, there exist no external substitutes, but the threat can arise only due to the presence of internal substitutes. However, the market is highly fragmented and faces intense internal competition at the product type level. For instance, consumers might substitute one brand of face cleanser for another brand, based on their preferences. On the other hand, the awareness and availability of various types of acne treatment products are growing in developing nations owing to the robust marketing strategies employed by the major players. By analyzing these various factors, it is identified that there are chances of product substitution at an internal level due to the availability of multiple options in the market.
Hence, the threat of substitutes in the global acne treatment market is low.
Intensity of Rivalry
The global acne treatment market is marked by a high intensity of rivalry. The established players are targeting competitors in terms of quality and price, making the industry competitive, in turn, reducing profit margins for all existing firms. Additionally, players operating in the market are competing by introducing new high-quality products.
The market players have high production capacities and focus on strategic investments in research and development. They invest in product development with changing consumer preferences to create differentiation. Key companies are identified to have strong relationships with retailers. Moreover, the key players in the global acne treatment market are emphasizing on various promotional activities to create awareness among consumers regarding product launches. Additionally, the manufacturers are actively promoting their products through advertisements on television, the internet, and other channels.
Therefore, the rivalry in the global acne treatment market is high.
Quantitative Analysis
Regional Breakdown
Regional market breakdown for Acne Treatment Market.
Regional Market Size (USD Mn)
Market estimates by geography (2027)
USD Mn
InsightEurope leads with $4.40B by 2027, while Asia Pacific is projected to grow fastest at a 5.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRegional Market Data
| REGION | 2017 | 2019 | 2027 | CAGR | SHARE |
|---|---|---|---|---|---|
| Europe | $2.83B | $3.50B | $4.40B | 4.5% | 59% |
| Asia Pacific | $548.54M | $622.52M | $905.56M | 5.1% | 12% |
| Middle East and Africa | $162.04M | $196.77M | $223.15M | 3.3% | 3% |
| Americas | $1.26B | $1.55B | $1.91B | 4.2% | 26% |
| Total | $4.80B | $5.87B | $7.43B | 4.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSegment Revenue (2027)
Moderate Acne
Mild Acne
Moderate to Severe Acne
0901180327043605
Segment Market Share
- Moderate Acne44%
- Mild Acne34%
- Moderate to Severe Acne22%
Total Market Size
$7.43B
Market by Segment (2027)
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Moderate Acne | $3.28B | 4.5% | 61% |
| Mild Acne | $2.50B | 4.5% | 60% |
| Moderate to Severe Acne | $1.65B | 4.5% | 82% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansEmpower your Business
with InsightsSave over 20% on
with Insights
Save over 20% on
Annual Subscription
See plans for professionals or small and medium businesses.
Analytics
Acne Treatment Market — Key Findings
Analytical insights on Acne Treatment Market covering market dynamics, competitive landscape, and strategic outlook.
Key Analytical Findings
The Acne Treatment Market market is projected to reach $7.43B by 2027, growing at 4.5% CAGR. The Moderate Acne segment holds the largest share.
Market Dynamics
Acne, also known as acne vulgaris, is a skin condition characterized by the clogging of hair follicles with oil or dead skin cells. The skin condition can be persistent even after treatments. Acne is estimated to affect the areas of the skin which have a relatively high number of oil glands, i.e., face, the upper part of the chest, and back. Pustules, nodules, cystic lesions, and papules are some of the common symptoms of the disease. Acne is common among teenagers. The increasing prevalence of the acne and growing teenage population are expected to fuel the growth of the acne treatment market.
The growth of the global acne treatment market is attributed to the high global acne prevalence, increasing sedentary lifestyle, and unhealthy food habits, high influence of social media and brand endorsements, and rise in disposable incomes of middle-class people.
However, safety issues regarding the products and failure of pivotal clinical trials for key candidates are restraining the growth of the market.
Market Drivers
Acne vulgaris is a common skin disease affecting approximately 9.4% of the world’s population, with the highest prevalence in adolescents. It affects over 90% of males and 80% of females in all ethnic groups. According to the American Academy of Dermatology Association, acne is the most common skin condition in the US, affecting 50 million Americans annually. It further stated that approximately 85% of people between the ages of 12 and 24 experience minor acne. In India, the prevalence data from a dermatology clinic in a teaching hospital in Varanasi reported acne in 50.6% of boys and 38.13% of girls in the age group 12-17 years. According to the Acne and Rosacea Society of Canada in 2016, acne affected ~90% of the teens in Canada. Moreover, it was estimated that ~5 million people within the region have acne. Furthermore, according to the Australian Journal of General Practice published by the Royal Australian College of General Practitioners, it is so common it can be considered almost universal in teenagers, with a prevalence of 93.3% in people aged 16–18 years in Australia. Other international studies have shown a prevalence of 85% in people aged 12–24 years and 64% and 43% in those aged 20–29 years and 30–39 years, respectively. Additionally, cosmetic expenditures and increasing awareness of the disease boosts the acne treatment market growth.
Market Opportunities
Globally, the demand for minimally invasive cosmetic treatment procedures is increasing significantly. Dermatologists prefer to treat skin diseases using topical applications or less invasive procedures rather than surgical methods. More informed decision making, better patient-physician relationships, and well-documented procedures are leading to increasing demand for treatments pertaining to face and skin related problems. This has been driving the adoption of various, less painful aesthetic combination therapy procedures. Furthermore, the increasing demand for faster treatments and quicker results are factors expected to drive demand for equipment-based procedures such as lasers. Marketing and advertising have played a major role in increasing awareness about current and upcoming acne treatments. The promotion of ideal beauty standards via online and offline campaigns has led people to buy more cosmetic products. Furthermore, acne-treating lotions and creams have also attracted voluminous demand in recent times. Henceforth, the global market for acne treatment is projected to attract voluminous revenues in the years to come.
Market Restraints
Side effects of acne treatments vary depending on the method you choose and the strength of the medication. For topical acne drugs, the most common side effects are skin dryness and irritation. The potential side effects of oral medications can be more serious. Antibiotics can upset the stomach or make patients dizzy and lightheaded. Moreover, oral isotretinoin can cause severe side effects, especially if the patient becomes pregnant while taking it. Severe birth defects have been reported in babies whose mothers took isotretinoin during pregnancy. The medication can also increase the risk of depression and suicidal thoughts and affect cholesterol levels and liver function. The safety issues regarding acne treatment products is expected to hamper the market growth.
Strategic Outlook and Future Directions
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Market Value by Segment (2027)
Value (USD Mn)
Moderate Acne
Mild Acne
Moderate to Severe Acne
Companies
Key companies profiled in Acne Treatment Market
Profiles of 108 companies operating in the Acne Treatment Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
Vyne Thera
Vyne Therapeutics Inc.
Healthcare
Company Headquarters: Bridgewater, US Founded: 2011 Workforce: ~ 40,039 Company Working: Vyne Therapeutics Inc., formerly known Menlo Therapeutics, focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions such as prurigo nodularis and psoriasis. It has a sales presence in the US and Israel.
Revenue$0.0B
Employees40,039
Market CapN/A
Founded2010
Bridgewater, US
Candela Co
Candela Corporation
Healthcare
Company Headquarters: Massachusetts, US Founded: 1970 Workforce: ~500-1000 Company Working: Candela Corporation is a global aesthetic medical device company which produces and distribute advance medical aesthetic solutions. The company advance technological products enable medical professionals to offer advanced energy-based solutions for a wide range of medical aesthetic application such as facial resurfacing, scars, benign vascular and pigmented lesions, hair removal, wrinkle reduction, and others. The company has extensive worldwide commercial and supply chain operations. In addition, the company directly distribute its products in 18 countries including US, Western Europe, Japan, China and also distribute indirectly in 66 countries across the globe. The company has strong business presence in North America, Europe, Asia-Pacific, and Rest of the World.
RevenueN/A
Employees1,000
Market CapN/A
Founded1969
Massachusetts, US
LEO Pharma
LEO Pharma A/S
Healthcare
Company Headquarters: Ballerup, Copenhagen, Denmark Founded: 1908 Workforce: ~5,820 Company Working: LEO Pharma A/S (LEO Pharma) is a global dermatology company. The company develops and markets products for dermatology, bone remodeling thrombosis, and coagulation. It provides products in multiple delivery systems such as topical, injections, and tablets. It operates through six major business segments, including Psoriasis, Eczema /Skin infection, Thrombosis, Acne/Rosacea, Actinic keratosis, and CMOs/Others. The company has a presence in more than 130 countries globally.
Revenue$1.6B
Employees5,820
Market CapN/A
Founded1907
Ballerup, Copenhagen, Denmark
Teva Pharm
Teva Pharmaceutical Industries Ltd
Healthcare
Company Headquarters: Petah Tikva, Israel Founded: 1901 Workforce: 43,000+ Company Working: Teva Pharmaceutical Industries Ltd (Teva) is one of the leaders in pharmaceutical industries engaged in developing and providing services in generic medicines. The company has more than 1,800 molecules which are used to create an extensive variety of generic products in almost every therapeutic area. It is specialized in generic medicines, the central nervous system (CNS), brand and specialty medicines, oncology, active pharmaceutical ingredients, respiratory, women's health, and biologics fields. It has more than 35,000 unique products, which is more than any other pharmaceutical company. Teva produced 120 billion tablets and capsules in 2017. Geographically, it operates in regions, namely, North America, Latin America, Europe, Japan, and South Korea. The company operates in more than 60 countries worldwide. It has 26 FDA approved plants, and 31 European Medicines Agency (EMA) approved plants worldwide.
Revenue$16.9B
Employees43,000
Market CapN/A
Founded1900
Petah Tikva, Israel
F. HOFFMAN
F. HOFFMANN-LA ROCHE LTD
Healthcare
Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.
Revenue$63.3B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Johnson &
Johnson & Johnson Services Inc.
Healthcare
Company Headquarters: New Jersey, US Founded: 1886 Workforce: ~130,000 Company Working: Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. Ethicon manufactures sutures, endocutters, breast care products, and energy-based products, like hand instruments, for tissue dissection. In 2016, Ethicon acquired NeuWave Medical, Inc.Johnson & Johnson is the world’s largest and broadly based healthcare company. It engages in the R&D, manufacture, and sale of products in the healthcare field. I Its pharmaceutical segment is focused on six therapeutic areas, including immunology, infectious diseases, oncology, cardiovascular and metabolism, and pulmonary hypertension t has more than 130 years of industry experience. The company has a team of 134,000 people at 260 companies in more than 60 countries around the globe.
Revenue$82.1B
Employees130,000
Market CapN/A
Founded1885
New Jersey, US
Page 1 of 18
…
Go to page
Powering the world's best teams.
From next-gen startups to established enterprises.
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Acne Treatment Market
Starting from
$4,950